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Narcolepsy or Gelineau syndrome
Tammy Rainey RN
Otterbein University, Westerville, Ohio

Excessive
Daytime
Sleepiness
(EDS)
Cataplexy

Sleep
Paralysis

Signs and
Symptoms

Narcolepsy is a
chronic
neurological
disease that
presents with an
individual having
difficulty
maintaining
continuous wake
and sleep cycles.

Hypnagogic/
Hypnopompic
Hallucinations

Disrupted
Nighttime
Sleep

Ancillary
symptoms

Gelineau syndrome, or narcolepsy was
named after the French neurologist JeanBaptiste-Édouard Gélineau (1859-1906).
Published by Gelineau in 1880 “the first case
reports in a bookbinder and a cooper (barrel
maker and seller)” (Mignot, 2014, p. 315).
The signs and symptoms of narcolepsy
include excessive daytime sleepiness (EDS)
in combination with rapid-eye movement
(REM) sleep dissociation, and disrupted
nighttime sleep. EDS is usually the first
symptom, and may have been going on for
some time, maybe years.
It is rare for all five symptoms to present
at the same time , usually <10 percent of
cases (Gupta, Sahoo, & Grover, 2017, p. 20).
Affecting males and females alike, symptoms
usually begin between the ages of 10 to 20
years of age, however, onset of the disease
can take place at any age. Diagnosis findings
shows peaks during adolescence age 15, and
a smaller peak at around 36 years of age
(Gupta et al., 2017, p. 20).
Cataplexy is sudden and brief periods when
the individual has a loss of muscle tone,
emotionally triggered, often by laughter, fear,
stress, anger or excitement. Onset of
cataplexy is typically secondary
to EDS, delayed by weeks, even years, and
may occur multiple times per day versus
once or twice in a lifetime.
Sleep paralysis is the temporary inability to
move or speak while falling asleep or
waking up usually lasts only a few seconds
or minutes and is similar to REM-induced
inhibitions of voluntary muscle activity.

Lack of clinical awareness about different presentations in adults, children, and adolescents, often
leads to misdiagnosis of narcolepsy as schizophrenia, epilepsy, and other neurological disorders
resulting in the incorrect prescribing of antipsychotic medications and antiepileptic medications.

Quick Facts
•

Underlying Pathophysiology
The exact cause of narcolepsy is not completely understood, however, the most current research suggests a
combination of biological and environmental factors which include the following:
•
Genetic predisposition
•
Stochastic factors leading to the generation of potential pathogenic naïve T cells
•
Inadequate central tolerance
•
Cross-stimulation with various environmental mimics at the wrong developmental time
•
Absence of peripheral tolerance
•
Penetration of culprit T cells into the central nervous system
•
Molecular mimicry
•
Destruction of hypocretin neurons by CD8+ T cells or other mechanisms (Mignot, 2014, p. 331).
What has been established is narcolepsy is caused by a lack of hypocretin, also known as orexin, which is a key
brain neurotransmitter produced in the hypothalamus. Hypocretin helps sustain alertness and prevent REM sleep
from occurring at inappropriate times.
Airway infections caused by H1N1 influenza A and streptococcus infection are suggested triggers to the autoimmune response that takes place with narcolepsy (Lopes et al., 2015, p. 49).

Pathological
Processes

While individuals may present with EDS,
they typically will experience fragmented
sleep, meaning they may have difficulty
staying asleep at night, or sleep for short
periods. “Sleep may be disrupted by vivid
dreaming, sleep apnea, acting out while
dreaming, and periodic leg movements”
(The National Institute of Neurological
Disorders and Stroke, 2018).
Ancillary symptoms may be experienced by
individuals with narcolepsy but are not
considered part of the diagnostic criteria.
These include automatic behaviors such as
when the person falls asleep during a
habitual activity like eating and automatically
continues the activity without awareness.
When the person awakens they do not recall
their actions. Recent studies show a cooccurrence of sleep and headache disorders
(Mitsikostas, Viskos, & Papadopoulos, 2010).

•

•

Sleep paralysis resembles cataplexy except
it occurs at the edges of sleep” (The National
Institute of Neurological Disorders and
Stroke, 2018).
Just as with sleep paralysis, hallucinations,
usually visual, may be experienced when
people are falling asleep or waking up,
defined as hypnagogic or hypnopompic
respectively, occurring in 83% of cases
(Gupta et al., 2017, p.22).

•

•

Pathophysiological model for narcolepsy (Mignot, E.J.M, 2014, p. 331).
Image retrieved from https://link.springer.com/search?query=history+of+narcolepsy

Significance of Pathophysiology
There are two major classifications of narcolepsy. Type 1 (previously known as
narcolepsy with cataplexy), in which the patient will have either low levels of
hypocretin or report cataplexy along with the cardinal symptom of EDS.
Type 2 narcolepsy (previously known as narcolepsy without cataplexy), in which the
patient will typically have less severe symptoms, not demonstrate cataplexy, and may
have normal hypocretin levels. There is a condition known as secondary narcolepsy
that results from injury to the hypothalamus (The National Institute of Neurological
Disorders and Stroke, 2018).
Streptococcus pyogenes and H1N1 virus may play a role in the development of
auto-immunity for the hypocretin-producing cells by stimulation of T or B cells
through a imitation or mimicking of molecular characteristics. Beginning with
streptococci super-antigens, along with the production of auto-antibodies, general
immune activation and migration of lymphocytes to the central nervous system.
Perhaps these pathogens have a tropism for the hypocretin-secreting neurons,
allowing activation of the microglia, and increasing the signals through the molecules
of the main histocompatibility complex (MHC) class II, inducing the neurotoxicity
through the release of quinolinic acid or glutaminase (Lopes et al., 2015, p.51).
The HLA-DQB1 gene provides instruction for making an important protein for the
immune system, and a version of this gene called HLA-DQB10602 increases the risk of
developing narcolepsy (The National Institute of Health, 2018).

Implications for Nursing Care

1 in 2000 individuals in
the U.S. and Western
Europe are affected by
Narcolepsy (National
Library of Medicine,
2018).

As was profoundly stated in the article by Mitsikostas et al., “Sleep is a mirror of
patients’ internal life.” Narcolepsy presents the same complexity as sleep disorders, and
co-occurrence of other disorders such as mood disorders and headache disorders is not
uncommon (Mitsikostas et al., 2010, p. 1240). Key points to appropriate narcolepsy
diagnosis will be:
MEDICATIONS FOR
•
A detailed medical history
TREATING DAYTIME
Genetic studies have
•
Symptom recognition
SLEEPINESS IN NARCOLEPSY
established nearly all
•
Testing such as Nocturnal Polysomnography (PSG)
Methylphenidate
patients (98%) with
followed by Multiple Sleep Latency testing (MSLT)
(brand
name:
Ritalin,
deficient hypocretin
•
Biomarker testing
Concerta,
Metadate,
levels are positive for
There are two sets of diagnostic criteria used for
Methylin)
human leukocyte antigen
diagnosis of narcolepsy: the International Classification
dextroamphetamine
(HLA) DQB1*0602 allele
of Sleep Disorders, third edition (ICSD-3) developed by
(Dexedrine)
(Gupta et al., 2017, p.22).
the American Academy of Sleep Medicine, and the
mixed amphetamine salts
Diagnostic and Statistical Manual of Mental Disorders,
(Adderall)
Onset of symptoms
fifth edition (DSM-5) developed by the American
modafinil (Provigil)
typically begin during
Psychiatric Association (designed for the general
armodafinil (Nuvigil)
adolescence, peak age 15
sodium
oxybate
(Xyrem)
practitioner who is not an expert in sleep medicine).
years. The birth month of
Both ICSD-3 and DSM-5 suggest use of hypocretin
March is also linked to a
MEDICATIONS FOR
deficiency as a diagnostic criterion, but must be carefully
higher risk of narcolepsy
TREATING
considered since it requires a lumbar puncture, and lacks
(Watson et al., 2012).
CATAPLEXY IN NARCOLEPSY
an assay that is commercially available for widespread
venlafaxine (Effexor)
Onset of symptoms to
use in clinical practice (Ruoff & Rye, 2016, p. 7).
fluoxetine
(Prozac)
diagnosis takes about 10
Although there is no cure for narcolepsy, symptoms
clomipramine (Anafranil)
to 15 years (Harvard
can typically be treated with medication and lifestyle
protriptyline (Vivactil)
Medical School Division
changes that include taking short naps, avoiding caffeine
sodium oxybate (Xyrem)
of Sleep, 2018).
or alcohol before bed, and no heavy meals before
bedtime.
A
detailed
medication
list
With both cataplexy and
with dose
Patients with severe symptoms will need to follow
sleep paralysis,
recommendations can be
state laws regulating individuals with epilepsy,
individuals remain fully
retrieved from
particularly with driving and operating heavy machinery.
conscious.
https:/healthysleep.med.
Reasonable accommodations must be made by
harvard.edu/narcolepsy
employers as part of The Americans with Disabilities Act
when it comes to modifying work schedules and
workload. Accommodations would apply to children
Daily periods of irrepressible need
and adolescents with special needs in the school
to sleep or daytime lapses into sleep
setting by modifying class schedules for administering
occurring for > 3 months
medications, taking naps, etc.
(The National Institute of Neurological
Disorders and Stroke, 2018)

Algorithm for
diagnostic
Workup
Bolded criteria required to satisfy narcolepsy diagnosis.
Diagnostic Items in subsequent boxes recommended but considered optional
(Ruoff & Rye, 2016, p. 9).

Conclusion

Although considered rare, the
neurological disorder narcolepsy
presents itself in the family of the author of this academic poster.
My paternal grandmother was diagnosed with narcolepsy as an
adult, and although I did not know her personally, I learned from
other family members the disease was quite debilitating for her.
My eldest daughter was diagnosed with narcolepsy as a teen.

Research of the disease lead me to discover that misdiagnosis is a
common theme with narcolepsy. As stated previously, more often
than not individuals are diagnosed with emotional or psychiatric
disorders and prescribed inappropriate medications, so it is my
hope and purpose the poster presentation will not only aid in a
better understanding of narcolepsy, but help guide clinicians to
appropriate and timely medical diagnosis of narcolepsy.

References cited
Gupta, A. K., Sahoo, S., & Grover, S. (2017).
Narcolepsy in Adolescence - A Missed
Diagnosis: A Case Report. Innovations in
Clinical Neuroscience, 14 (9-10), 20-23
Harvard Medical School Division of Sleep
Medicine. (2018). Narcolepsy.
https://healthysleep.med.harvard.edu/nar
colepsy
Lopes, D. A., Santos Coelho, F. M., PradellaHalllinan, M., de Araujo Melo, M. H., &
Tufik, S. (2015). Infancy narcolepsy:
Streptococcus infection as a causal factor.
Sleep Science, 8 (1), 49-52.
https://dx.doi.org/10.1016/j.slsci.2015.02.
002
Mignot, E. J. M. (2014). History of narcolepsy at
Stanford University. Immunologic
Research, 58, 315-339.
https://doi.org/10.1007/s12026-0148513-4
Mitsikostas, D. D., Viskos, A., & Papadopoulos,
D. (2010). Sleep and Headache: The
Clinical Relationship.
https://doi.org/10.1111/j.15264610.2010.01729.x
National Library of Medicine. (2018). Genetics
Home Reference – Your Guide to
Understanding Genetic Conditions.
Retrieved from
https://ghr.nlm.nih.gov/gene/HLA-DQB1
Ruoff, C., and Rye, D. (2016). The ICSD-3 and
DSM-5 guidelines for diagnosing
narcolepsy: clinical relevance and
practicality.
http://dx.doi.org/10.1080/03007995.201
6.1208643
The National Institutes of Health. (2018).
Genetics Home Reference: Your Guide to
Understanding Genetic Conditions.
Retrieved from
https://ghr.nlm.nih.gov/condition/narcole
psy
The National Institute of Neurological
Disorders and Stroke. (2018). Narcolepsy
Fact Sheet. Retrieved from
https://www.ninds.nih.gov/Disorders/AllDisorders/Narcolepsy-InformationPage#disorders-r2
Watson, N. F., Ton, T. G. N., Koepsell, T. D., &
Longstreth, W. T. (2012). Birth order and
narcolepsy risk among genetically
susceptible individuals: A populationbased case-control study. Sleep Medicine,
13(3), 310–313.
http://doi.org/10.1016/j.sleep.2011.09.01

